🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1\. Purpose of the Study - This protocol aims to demonstrate the feasibilit...
Status
Completed
Location
Duke University Medical Center
Start Date
2012-06
Trial ID
NCT01639612
Treatments Being Tested
In this study 1. Assess the efficiency of non-cultured autologous keratino...
Status
Unknown
Location
Multiple Locations
Start Date
2020-11-01
Trial ID
NCT03686449
The primary purpose of this study is to determine the safety and efficacy o...
Status
Unknown
Location
The Affiliated People's Hospital of Ningbo University
Start Date
2021-09-16
Trial ID
NCT05528887
Treatments Being Tested
1. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Status
Completed
Location
National University Hospital
Start Date
2007-05
Trial ID
NCT00717184
Treatments Being Tested
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
The purpose of this study is to investigate the efficacy and safety of auto...
Status
Completed
Location
Royan Institute
Start Date
2008-08
Trial ID
NCT00850187
Treatments Being Tested
Skin graft is a commonly used method in wound repair. The long-term outcome...
Status
Unknown
Location
Multiple Locations
Start Date
2020-10-01
Trial ID
NCT04532593
Treatments Being Tested
Multiple system atrophy (MSA) is a rare, rapidly progressive, and invariabl...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2021-12-15
Trial ID
NCT05167721
Treatments Being Tested
This is a human clinical study involving the isolation of autologous bone m...
Status
Recruiting
Location
MD Stem Cells
Start Date
2016-06
Trial ID
NCT02795052
Treatments Being Tested
RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Status
Unknown
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Start Date
2015-10
Trial ID
NCT02580747
Treatments Being Tested